Atropine Sulfate Injection, Solution
Product Images NDC 0404-9804

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 0404-9804). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure of Atropine Sulfate, showing the molecular arrangement of the atropine component complexed with sulfuric acid and water molecules, consistent with the sulfate salt form.*

FDA Label Image

Image1.jpg (Image1)

A dosing guideline table for Atropine Sulfate injection, solution. It details initial doses and continued treatment for uses such as antisialagogue effects, organophosphorus or muscarinic mushroom poisoning, and symptomatic bradycardia. Notes include routes of administration, dosing intervals, maximum total doses, and specific contraindications for certain cardiac conditions.*

FDA Label Image

Image2.jpg (Image2)

A data table presenting dosing information for Atropine Sulfate injection, solution, 0.4 mg/mL. It details initial doses, routes of administration (IV, IM, SC, IO, ET), and continued treatment guidelines for different clinical uses including antisialagogue and antivagal effects during surgery, organophosphorus poisoning, and symptomatic bradycardia. Maximum single and total doses are specified for pediatric and adult patients.*

FDA Label Image

Image3.jpg (Image3)

A data table comparing two presentations of a pharmaceutical product: Single Vial and 10 Vial Pack. The Single Vial has NDC 63323-580-03 and contains 8 mg per 20 mL (0.4 mg/mL) in a multiple-dose vial. The 10 Vial Pack has NDC 63323-580-20, with each 20 mL multiple-dose vial packaged in a carton of 10 vials.*

FDA Label Image

Image4.jpg (Image4)

FDA Label Image

Label1.jpg (Label1)

Atropine Sulfate 0.4 mg/mL injection solution, 20 mL multiple dose vial label from Henry Schein, Inc. The label includes dosing strength as 8 mg per 20 mL, routes of administration (intravenous, intramuscular, subcutaneous, intraosseous, endotracheal), storage instructions after initial use, and the NDC 0404-9804-20.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.